穆克吉也将他自己的病人的故事写进了这部历史，虽然这些故事并不总是一帆风顺。
Mukherjee stitches stories of his own patients into this history, not always smoothly.
结论：吉西他滨联合顺铂的新辅助化疗耐受性好，并且没有破坏胰腺癌的可手术性。
Conclusion: Neoadjuvant chemotherapy with gemcitabine and cisplatin is well tolerated and does not impair resectability of pancreatic cancer.
同时，这些患者既往不能有包含吉西他滨或者顺铂的化疗史。
Patients could not have had prior chemotherapy with gemcitabine or cisplatin.
应用推荐